Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors
Author(s): Christina Magnussen Added: 1 year ago
ACC 2025 - Individual-level data collected across 126 worldwide cohorts show controlling modifiable cardiovascular risk factors can potentially benefit life-years for freedom from CVD and death from any cause.Prof Christina Magnussen (University Heart and Vascular Centre Hamburg, Hamberg, DE) joins us onsite at ACC to discuss modifiable cardiovascular risk factors collected by the Global… View more

Cardiovascular Kidney Metabolic
Research Area(s) / Expertise:
ACC 26: AI-Based Retinal Imaging for Atherosclerotic Cardiovascular Risk
Author(s): Michael McConnell Added: 1 month ago
ACC.26 – Dr Michael McConnell (Stanford Health Care, Stanford, CA, US) joins us to discuss findings from a prospective, multicentre clinical trial evaluating whether artificial intelligence analysis of retinal images can identify patients at elevated atherosclerotic cardiovascular risk.Findings showed strong sensitivity and specificity in identifying those at risk of ASCVD in a diverse study… View more

Prevention & Chronic Conditions

Digital Health
Between the Sessions with Dr Parwani: VESALIUS-CV, KARDINAL, CHIP-BCIS3 & M
Author(s): Purvi Parwani Added: 1 month ago
Dr Purvi Parwani (Loma Linda University Health, US) recaps the standout science from Day 2 of ACC 2026, a day defined by a central theme: challenging long-held assumptions in cardiology. Her summary focuses on what these updates mean for day-to-day clinical practice, from prevention strategies to interventional decision-making.Prevention and Risk ReductionVESALIUS-CV: Showed a 25% reduction in… View more

Intervention

Prevention & Chronic Conditions
ESC 25 Guidelines Discussion: Management of Dyslipidaemias
Author(s): Harriette Van Spall , Jeanine Roeters Van Lennep Added: 8 months ago
ESC Congress 2025 - Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Professor Jeanine Roeters van Lennep (Erasmus Medical Center, NL) to discuss the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias.This focused update delivers the most current, evidence-based recommendations for lipid management and cardiovascular risk… View more

Guidelines & Statements

Prevention & Chronic Conditions
New Horizons in Dyslipidaemia 2026
Start date: Feb 12, 2026 End date: Feb 12, 2026
New Horizons in Dyslipidaemia is a free-to-access, one-day virtual educational event on 12 February 2026, developed for healthcare professionals involved in cardiovascular risk assessment and lipid management.The programme will explore the rapidly evolving landscape of lipid management, addressing gaps between perceived and actual cardiovascular risk and the underutilisation of effective… View more

Prevention & Chronic Conditions
Research Area(s) / Expertise:

Diabetes

 Job title: Attending Physician
Dr Chern-En Chiang is an Attending Physician at theTaipei Veterans General Hospital in Taipei, Taiwan. He gained his MD at the National Yang-Ming University School of Medicine, and studied his PhD at the same institution. His research interests include arrhythmias, hypertension, and hyperlipidemia. Dr Chern-En Chiang is a member of the editorial board for theJournal of Asian Pacific Society of… View more
Job title: Associate Professor of Internal Medicine-Hypertension
Kelvin Lee
Job title: Consultant Interventional Cardiologist
Prof Kelvin Lee is Consultant Interventional Cardiologist at the Lincolnshire Heart Centre with a focus on complex coronary intervention. His expertise includes intra-coronary imaging, rotational atherectomy, intravascular lithotripsy and coronary physiology using iFR and FFR. He leads the Cardiovascular Clinical Research Programme and is Cardio-Metabolic Lead and Deputy Clinical Director of… View more
New Horizons in Dyslipidaemia
Author(s): Peter Libby, Kausik Ray, Erik Stroes Start date: Feb 12, 2026
Join us forNew Horizons in Dyslipidaemia, a new one-day virtual educational event, taking place on 12 February 2026, designed for healthcare professionals involved in the management of cardiovascular risk and other lipid-related health conditions.This event will explore the rapidly evolving landscape of lipid management, addressing persistent gaps between perceived and actual cardiovascular risk… View more

Prevention & Chronic Conditions